General Information of the Compound
Compound ID
CP0530135
Compound Name
3-[2-(2,5-dimethoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)quinazolin-4-one
    Show/Hide
Structure
Formula
C21H20N4O3
Molecular Weight
376.416
Canonical SMILES
COc1ccc(OC)c(CCn2cnc3ccc(cc3c2=O)-c2cn[nH]c2)c1
    Show/Hide
InChI
InChI=1S/C21H20N4O3/c1-27-17-4-6-20(28-2)15(9-17)7-8-25-13-22-19-5-3-14(10-18(19)21(25)26)16-11-23-24-12-16/h3-6,9-13H,7-8H2,1-2H3,(H,23,24)
    Show/Hide
InChIKey
SFBQPOFFSZXYHF-UHFFFAOYSA-N
Physicochemical Property
logP
3.0465
Rotatable Bonds
6
Heavy Atom Count
28
Polar Areas
82.03
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155565293
ChEMBL ID
CHEMBL4579969
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03393, P2X purinoceptor 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS